Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 5, 2026.

Human MHC architecture and evolution: implications for disease association studies

J. A. Traherne

International Journal of Immunogenetics · 2008 · Review

doi:10.1111/j.1744-313x.2008.00765.x

Abstract

Summary Major histocompatibility complex (MHC) variation is a key determinant of susceptibility and resistance to a large number of infectious, autoimmune and other diseases. Identification of the MHC variants conferring susceptibility to disease is problematic, due to high levels of variation and linkage disequilibrium. Recent cataloguing and analysis of variation over the complete MHC has facilitated localization of susceptibility loci for autoimmune diseases, and provided insight into the MHC's evolution. This review considers how the unusual genetic characteristics of the MHC impact on strategies to identify variants causing, or contributing to, disease phenotypes. It also considers the MHC in relation to novel mechanisms influencing gene function and regulation, such as epistasis, epigenetics and microRNAs. These developments, along with recent technological advances, shed light on genetic association in complex disease.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 96

  1. 1.

    Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature. 2006;439:851.

    Not in our library10.1038/nature04489

  2. 2.

    Apanius V, Penn D, Slev PR, Ruff LR, Potts WK. The nature of selection on the major histocompatibility complex. Critical Reviews in Immunology. 1997;17:179.

    Not in our library10.1615/critrevimmunol.v17.i2.40

  3. 3.

    Baena A, Mootnick AR, Falvo JV, Tsytskova AV, Ligeiro F, Diop OM, et al. Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity. PLoS ONE. 2007;2:e621.

    Not in our library10.1371/journal.pone.0000621

  4. 4.

    de Bakker PI, Burtt NP, Graham RR, Guiducci C, Yelensky R, Drake JA, et al. Transferability of tag SNPs in genetic association studies in multiple populations. Nature Genetics. 2006a;38:1298.

    Not in our library10.1038/ng1899

  5. 5.

    de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nature Genetics. 2006b;38:1166.

    Not in our library10.1038/ng1885

  6. 6.

    Bansal V, Bashir A, Bafna V. Evidence for large inversion polymorphisms in the human genome from HapMap data. Genome Research. 2007;17:219.

    Not in our library10.1101/gr.5774507

  7. 7.

    Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Human Molecular Genetics. 2006;15:2813.

    Not in our library10.1093/hmg/ddl223

  8. 8.

    Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129:823.

    Not in our library10.1016/j.cell.2007.05.009

  9. 9.

    Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;128:669.

    Not in our library10.1016/j.cell.2007.01.033

  10. 10.

    Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends in Genetics. 2004;20:350.

    Not in our library10.1016/j.tig.2004.06.009

  11. 11.

    Boyle LH, Gillingham AK, Munro S, Trowsdale J. Selective export of HLA-F by its cytoplasmic tail. Journal of Immunology. 2006;176:6464.

    Not in our library10.4049/jimmunol.176.11.6464

  12. 12.

    Boyle LH, Traherne JA, Plotnek G, Ward R, Trowsdale J. Splice variation in the cytoplasmic domains of myelin oligodendrocyte glycoprotein affects its cellular localisation and transport. Journal of Neurochemistry. 2007;102:1853.

    Not in our library10.1111/j.1471-4159.2007.04687.x

  13. 13.

    Cabestre FA, Lefebvre S, Moreau P, Rouas-Friess N, Dausset J, Carosella ED, Paul P. HLA-G expression: immune privilege for tumour cells? Seminars in Cancer Biology. 1999;9:27.

    Not in our library10.1006/scbi.1998.0104

  14. 14.

    Chung EK, Yang Y, Rennebohm RM, Lokki ML, Higgins GC, Jones KN, Zhou B, Blanchong CA, Yu CY. Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. American Journal of Human Genetics. 2002;71:823.

    Not in our library10.1086/342777

  15. 15.

    Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. A high-resolution survey of deletion polymorphism in the human genome. Nature Genetics. 2006;38:75.

    Not in our library10.1038/ng1697

  16. 16.

    Crews D, Gore AC, Hsu TS, Dangleben NL, Spinetta M, Schallert T, Anway MD, Skinner MK. Transgenerational epigenetic imprints on mate preference. Proceedings of the National Academy of Sciences USA. 2007;104:5942.

    Not in our library10.1073/pnas.0610410104

  17. 17.

    De Tomaso AW, Nyholm SV, Palmeri KJ, Ishizuka KJ, Ludington WB, Mitchel K, Weissman IL. Isolation and characterization of a protochordate histocompatibility locus. Nature. 2005;438:454.

    Not in our library10.1038/nature04150

  18. 18.

    Distante S, Robson KJ, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M. The origin and spread of the HFE-C282Y haemochromatosis mutation. Human Genetics. 2004;115:269.

    Not in our library10.1007/s00439-004-1152-4

  19. 19.

    Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, et al. A genome-wide association study of global gene expression. Nature Genetics. 2007;39:1202.

    Not in our library10.1038/ng2109

  20. 20.

    Eagle RA, Traherne JA, Ashiru O, Wills MR, Trowsdale J. Regulation of NKG2D ligand gene expression. Human Immunology. 2006;67:159.

    Not in our library10.1016/j.humimm.2006.02.015

  21. 21.

    Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nature Genetics. 2006;38:1378.

    Not in our library10.1038/ng1909

  22. 22.

    Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433.

    Not in our library10.1038/nature05919

  23. 23.

    Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317:944.

    Not in our library10.1126/science.1143767

  24. 24.

    Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. American Journal of Human Genetics. 2006;79:439.

    Not in our library10.1086/505915

  25. 25.

    Flanagan JM, Popendikyte V, Pozdniakovaite N, Sobolev M, Assadzadeh A, Schumacher A, et al. Intra- and interindividual epigenetic variation in human germ cells. American Journal of Human Genetics. 2006;79:67.

    Not in our library10.1086/504729

  26. 26.

    Flores M, Morales L, Gonzaga-Jauregui C, Dominguez-Vidana R, Zepeda C, Yanez O, et al. Recurrent DNA inversion rearrangements in the human genome. Proceedings of the National Academy of Sciences USA. 2007;104:6099.

    Not in our library10.1073/pnas.0701631104

  27. 27.

    Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:851.

    Not in our library10.1038/nature06258

  28. 28.

    Friaes A, Rego AT, Aragues JM, Moura LF, Mirante A, Mascarenhas MR, et al. CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Molecular Genetics Metabolism. 2006;88:58.

    Not in our library10.1016/j.ymgme.2005.11.015

  29. 29.

    Gherman A, Chen PE, Teslovich TM, Stankiewicz P, Withers M, Kashuk CS, Chakravarti A, Lupski JR, Cutler DJ, Katsanis N. Population Bottlenecks as a Potential Major Shaping Force of Human Genome Architecture. PLoS Genetics. 2007;3:e119.

    Not in our library10.1371/journal.pgen.0030119

  30. 30.

    Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, et al. The influence of CCL3L1 ene-containing segmental duplications on HIV-1/AIDS susceptibility. Science. 2005;307:1434.

    Not in our library10.1126/science.1101160

  31. 31.

    Greetham D, Ellis CD, Mewar D, Fearon U, Nic An Ultaigh S, Veale DJ, Guesdon F, Wilson AG. Functional characterisation of NF-{kappa}B inhibitor-like protein 1 (NF{kappa}BIL1), a candidate susceptibility gene for rheumatoid arthritis. Human Molecular Genetics. 2007;16:3027.

    Not in our library10.1093/hmg/ddm261

  32. 32.

    Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen AR, Cardon LR, Bell JI, Fugger L. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature. 2006;443:574.

    Not in our library10.1038/nature05133

  33. 33.

    Guethlein LA, Older Aguilar AM, Abi-Rached L, Parham P. Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. Journal of Immunology. 2007;179:491.

    Not in our library10.4049/jimmunol.179.1.491

  34. 34.

    Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, Almeida J, et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics. 2008;60:1.

    Not in our library10.1007/s00251-007-0262-2

  35. 35.

    Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nature Reviews. Genetics. 2004;5:889.

    Not in our library10.1038/nrg1489

  36. 36.
  37. 37.

    Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nature Reviews. Genetics. 2007;8:253.

    Not in our library10.1038/nrg2045

  38. 38.

    Kapp C. WHO warns of microbial threat. Lancet. 1999;353:2222.

    Not in our library10.1016/s0140-6736(05)76281-4

  39. 39.

    Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316:1484.

    Not in our library10.1126/science.1138341

  40. 40.

    Khaja R, Zhang J, MacDonald JR, He Y, Joseph-George AM, Wei J, et al. Genome assembly comparison identifies structural variants in the human genome. Nature Genetics. 2006;38:1413.

    Not in our library10.1038/ng1921

  41. 41.

    Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunological Reviews. 2006;214:186.

    Not in our library10.1111/j.1600-065x.2006.00459.x

  42. 42.

    Koeleman BP, Lie BA, Undlien DE, Dudbridge F, Thorsby E, de Vries RR, Cucca F, Roep BO, Giphart MJ, Todd JA. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes and Immunity. 2004;5:381.

    Not in our library10.1038/sj.gene.6364106

  43. 43.

    Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, Simons JF, et al. Paired-end mapping reveals extensive structural variation in the human genome. Science. 2007;318:420.

    Not in our library10.1126/science.1149504

  44. 44.

    Kralovicova J, Houngninou-Molango S, Kramer A, Vorechovsky I. Branch site haplotypes that control alternative splicing. Human Molecular Genetics. 2004;13:3189.

    Not in our library10.1093/hmg/ddh334

  45. 45.

    Lee HH, Tsai FJ, Lee YJ, Yang YC. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P. Molecular Genetics and Metabolism. 2006;88:372.

    Not in our library10.1016/j.ymgme.2006.03.013

  46. 46.

    Lippman Z, Martienssen R. The role of RNA interference in heterochromatic silencing. Nature. 2004;431:364.

    Not in our library10.1038/nature02875

  47. 47.

    Liu X, Fu Y, Liu Z, Lin B, Xie Y, Liu Y, et al. An ancient balanced polymorphism in a regulatory region of human major histocompatibility complex is retained in Chinese minorities but lost worldwide. American Journal of Human Genetics. 2006;78:393.

    Not in our library10.1086/500593

  48. 48.

    Loisel DA, Rockman MV, Wray GA, Altmann J, Alberts SC. Ancient polymorphism and functional variation in the primate MHC-DQA1 5′-cis-regulatory region. Proceedings of the National Academy of Sciences USA. 2006;103:163316.

    Not in our library10.1073/pnas.0607662103

  49. 49.

    Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nature Genetics. 2007;39:733.

    Not in our library10.1038/ng2035

  50. 50.

    Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007;448:553.

    Not in our library10.1038/nature06008

  51. 51.

    Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, Hunt S, et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. American Journal of Human Genetics. 2005;76:634.

    Not in our library10.1086/429393

  52. 52.

    Moalem S, Storey KB, Percy ME, Peros MC, Perl DP. The sweet thing about type 1 diabetes: a cryoprotective evolutionary adaptation. Medical Hypotheses. 2005;65:8.

    Not in our library10.1016/j.mehy.2004.12.025

  53. 53.

    Mouillot G, Marcou C, Rousseau P, Rouas-Freiss N, Carosella ED, Moreau P. HLA-G gene activation in tumor cells involves cis-acting epigenetic changes. International Journal of Cancer. 2005;113:928.

    Not in our library10.1002/ijc.20682

  54. 54.

    Murrell A, Rakyan VK, Beck S. From genome to epigenome. Human Molecular Genetics. 2005;14:R3-R10.

    Not in our library10.1093/hmg/ddi110

  55. 55.

    Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007;450:887.

    Not in our library10.1038/nature06406

  56. 56.

    Neumann R, Jeffreys AJ. Polymorphism in the activity of human crossover hotspots independent of local DNA sequence variation. Human Molecular Genetics. 2006;15:1401.

    Not in our library10.1093/hmg/ddl063

  57. 57.

    Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. American Journal of Human Genetics. 2004;74:160.

    Not in our library10.1086/380997

  58. 58.

    Parham P. MHC class I molecules and KIRs in human history, health and survival. Nature Reviews. Immunology. 2005;5:201.

    Not in our library10.1038/nri1570

  59. 59.

    Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. Journal of Immunology. 2006;176:4323.

    Not in our library10.4049/jimmunol.176.7.4323

  60. 60.

    Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, Balloux F. Pathogen-driven selection and worldwide HLA class I diversity. Current Biology. 2005;15:1022.

    Not in our library10.1016/j.cub.2005.04.050

  61. 61.
  62. 62.

    Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 2007;129:879.

    Not in our library10.1016/j.cell.2007.03.043

  63. 63.

    Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, et al. Ancient haplotypes of the HLA class II region. Genome Research. 2005;15:1250.

    Not in our library10.1101/gr.3554305

  64. 64.

    Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature. 2006;444:444.

    Not in our library10.1038/nature05329

  65. 65.

    Rodriguez-Rodero S, Gonzalez S, Rodrigo L, Fernandez- Morera JL, Martinez-Borra J, Lopez-Vazquez A, Lopez-Larrea C. Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. European Journal of Immunology. 2007;37:1938.

    Not in our library10.1002/eji.200737031

  66. 66.

    Rollinger-Holzinger I, Eibl B, Pauly M, Griesser U, Hentges F, Auer B, et al. LST1: a gene with extensive alternative splicing and immunomodulatory function. Journal of Immunology. 2000;164:3169.

    Not in our library10.4049/jimmunol.164.6.3169

  67. 67.

    Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, Cotsapas C, et al. Genome-wide detection and characterization of positive selection in human populations. Nature. 2007;449:913.

    Not in our library10.1038/nature06250

  68. 68.

    von Salome J, Gyllensten U, Bergstrom TF. Full-length sequence analysis of the HLA-DRB1 locus suggests a recent origin of alleles. Immunogenetics. 2007;59:261.

    Not in our library10.1007/s00251-007-0196-8

  69. 69.

    Sen SK, Han K, Wang J, Lee J, Wang H, Callinan PA, Dyer M, Cordaux R, Liang P, Batzer MA. Human genomic deletions mediated by recombination between Alu elements. American Journal of Human Genetics. 2006;79:41.

    Not in our library10.1086/504600

  70. 70.

    Shen P, Huang HV. Effect of base pair mismatches on recombination via the RecBCD pathway. Molecular General Genetics. 1989;218:358.

    Not in our library10.1007/bf00331291

  71. 71.

    Shiina T, Ota M, Shimizu S, Katsuyama Y, Hashimoto N, Takasu M, et al. Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity. Genetics. 2006;173:1555.

    Not in our library10.1534/genetics.106.057034

  72. 72.

    Single RM, Martin MP, Gao X, Meyer D, Yeager M, Kidd JR, Kidd KK, Carrington M. Global diversity and evidence for coevolution of KIR and HLA. Nature Genetics. 2007;39:1114.

    Not in our library10.1038/ng2077

  73. 73.

    Smith WP, Vu Q, Li SS, Hansen JA, Zhao LP, Geraghty DE. Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes. Genomics. 2006;87:561.

    Not in our library10.1016/j.ygeno.2005.11.020

  74. 74.

    Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nature Genetics. 2007;39:226.

    Not in our library10.1038/ng1955

  75. 75.

    Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, et al. Host immune system gene targeting by a viral miRNA. Science. 2007;317:376.

    Not in our library10.1126/science.1140956

  76. 76.

    Stewart CA, Horton R, Allcock RJ, Ashurst JL, Atrazhev AM, Coggill P, et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Research. 2004;14:1176.

    Not in our library10.1101/gr.2188104

  77. 77.

    A haplotype map of the human genome. Nature. 2005;437:1299.

    Not in our library10.1038/nature04226

  78. 78.

    A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:851.

    Not in our library10.1038/nature06258

  79. 79.

    Thorisson GA, Smith AV, Krishnan L, Stein LD. The International HapMap Project website. Genome Research. 2005;15:1592.

    Not in our library10.1101/gr.4413105

  80. 80.

    Traherne JA, Barcellos LF, Sawcer SJ, Compston A, Ramsay PP, Hauser SL, Oksenberg JR, Trowsdale J. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Human Molecular Genetics. 2006a;15:155.

    Not in our library10.1093/hmg/ddi436

  81. 81.
  82. 82.

    Venkataraman GM, Suciu D, Groh V, Boss JM, Spies T. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. Journal of Immunology. 2007;178:961.

    Not in our library10.4049/jimmunol.178.2.961

  83. 83.
  84. 84.

    Wang GS, Cooper TA. Splicing in disease: disruption of the splicing code and the decoding machinery. Nature Reviews. Genetics. 2007;8:749.

    Not in our library10.1038/nrg2164

  85. 85.

    Wang Y, Curry HM, Zwilling BS, Lafuse WP. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. Journal of Immunology. 2005;174:5687.

    Not in our library10.4049/jimmunol.174.9.5687

  86. 86.

    Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A, Weller M. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. Journal of Immunology. 2002;168:4772.

    Not in our library10.4049/jimmunol.168.9.4772

  87. 87.

    Wong KK, deLeeuw RJ, Dosanjh NS, Kimm LR, Cheng Z, Horsman DE, et al. A comprehensive analysis of common copy-number variations in the human genome. American Journal of Human Genetics. 2007;80:91.

    Not in our library10.1086/510560

  88. 88.

    Wright KL, Ting JP. Epigenetic regulation of MHC-II and CIITA genes. Trends in Immunology. 2006;27:405.

    Not in our library10.1016/j.it.2006.07.007

  89. 89.

    Genome–wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447:661.

    Not in our library10.1038/nature05911

  90. 90.

    Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, Spies T. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. Journal of Immunology. 2003;170:4196.

    Not in our library10.4049/jimmunol.170.8.4196

  91. 91.

    Wurtele H, Gusew N, Lussier R, Chartrand P. Characterization of vivo recombination activities in the mouse embryo. Molecular Genetics and Genomics. 2005;273:252.

    Not in our library10.1007/s00438-005-1112-2

  92. 92.

    Yamazaki K, Beauchamp GK. Genetic basis for MHC-dependent mate choice. Advances in Genetics. 2007;59:129.

    Not in our library10.1016/s0065-2660(07)59005-x

  93. 93.

    Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. American Journal of Human Genetics. 2007;80:1037.

    Not in our library10.1086/518257

  94. 94.
  95. 95.

    Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nature Reviews. Drug Discovery. 2006;5:37.

    Not in our library10.1038/nrd1930

  96. 96.

    Zhi D. Sequence correlation between neighboring Alu instances suggests post-retrotransposition sequence exchange due to Alu gene conversion. Gene. 2007;390:117.

    Not in our library10.1016/j.gene.2006.09.030

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.